Annual Retained Earnings
-$471.56 M
-$98.43 M-26.38%
December 31, 2023
Summary
- As of February 7, 2025, FHTX annual retained earnings is -$471.56 million, with the most recent change of -$98.43 million (-26.38%) on December 31, 2023.
- During the last 3 years, FHTX annual retained earnings has fallen by -$308.63 million (-189.42%).
- FHTX annual retained earnings is now -996.46% below its all-time high of -$43.01 million, reached on December 31, 2018.
Performance
FHTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$538.68 M
-$19.12 M-3.68%
September 30, 2024
Summary
- As of February 7, 2025, FHTX quarterly retained earnings is -$538.68 million, with the most recent change of -$19.12 million (-3.68%) on September 30, 2024.
- Over the past year, FHTX quarterly retained earnings has dropped by -$91.22 million (-20.39%).
- FHTX quarterly retained earnings is now -472.24% below its all-time high of -$94.14 million, reached on December 31, 2019.
Performance
FHTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
FHTX Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -26.4% | -20.4% |
3 y3 years | -189.4% | -33.5% |
5 y5 years | -996.5% | -33.5% |
FHTX Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -78.5% | at low | -103.8% | at low |
5 y | 5-year | -400.9% | at low | -472.2% | at low |
alltime | all time | -996.5% | at low | -472.2% | at low |
Foghorn Therapeutics Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -$538.68 M(+3.7%) |
Jun 2024 | - | -$519.56 M(+4.6%) |
Mar 2024 | - | -$496.58 M(+5.3%) |
Dec 2023 | -$471.56 M(+26.4%) | -$471.56 M(+5.4%) |
Sep 2023 | - | -$447.46 M(+3.3%) |
Jun 2023 | - | -$433.11 M(+7.3%) |
Mar 2023 | - | -$403.63 M(+8.2%) |
Dec 2022 | -$373.14 M | -$373.14 M(+8.4%) |
Sep 2022 | - | -$344.25 M(+8.1%) |
Jun 2022 | - | -$318.48 M(+9.4%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | -$291.17 M(+10.2%) |
Dec 2021 | -$264.26 M(+62.2%) | -$264.26 M(+12.4%) |
Sep 2021 | - | -$235.11 M(+12.5%) |
Jun 2021 | - | -$209.03 M(+12.4%) |
Mar 2021 | - | -$185.92 M(+14.1%) |
Dec 2020 | -$162.94 M(+73.1%) | -$162.94 M(+14.6%) |
Sep 2020 | - | -$142.18 M(+14.8%) |
Jun 2020 | - | -$123.81 M(+31.5%) |
Dec 2019 | -$94.14 M(+118.9%) | -$94.14 M |
Dec 2018 | -$43.01 M | - |
FAQ
- What is Foghorn Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual retained earnings year-on-year change?
- What is Foghorn Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly retained earnings year-on-year change?
What is Foghorn Therapeutics annual retained earnings?
The current annual retained earnings of FHTX is -$471.56 M
What is the all time high annual retained earnings for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual retained earnings is -$43.01 M
What is Foghorn Therapeutics annual retained earnings year-on-year change?
Over the past year, FHTX annual retained earnings has changed by -$98.43 M (-26.38%)
What is Foghorn Therapeutics quarterly retained earnings?
The current quarterly retained earnings of FHTX is -$538.68 M
What is the all time high quarterly retained earnings for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly retained earnings is -$94.14 M
What is Foghorn Therapeutics quarterly retained earnings year-on-year change?
Over the past year, FHTX quarterly retained earnings has changed by -$91.22 M (-20.39%)